Hyperfine (NASDAQ:HYPR) Stock Rating Cut to Sell at Wall Street Zen

Wall Street Zen lowered shares of Hyperfine (NASDAQ:HYPR) from a hold rating to a sell rating in a research note issued to investors on Saturday,Wall Street Zen reports.

HYPR has been the topic of several other reports. B. Riley Financial reiterated a “buy” rating and issued a $1.60 price objective (down from $2.00) on shares of Hyperfine in a report on Monday, August 10th. Lucid Cap Mkts assumed coverage on shares of Hyperfine in a research note on Tuesday, October 27th. They set a “strong-buy” rating for the company. BTIG Research reaffirmed a “buy” rating and set a $2.00 target price on shares of Hyperfine in a report on Tuesday, September 22nd. Loop Capital set a $2.00 target price on shares of Hyperfine in a report on Tuesday. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $2.02.

Hyperfine Stock Down 3.2%

Shares of HYPR stock opened at $0.72 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 5.45 and a current ratio of 6.15. The firm’s 50-day moving average is $0.81 and its 200-day moving average is $1.12. The stock has a market cap of $76.36 million, a price-to-earnings ratio of -1.89 and a beta of 1.45. Hyperfine has a 52-week low of $0.70 and a 52-week high of $1.94.

Hyperfine (NASDAQ:HYPR) last issued its earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.09). The business had revenue of $3.90 million during the quarter, compared to the consensus estimate of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. Sell-side analysts predict that Hyperfine will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Hyperfine

Several institutional investors have recently made changes to their positions in the stock. PFS Partners LLC increased its position in shares of Hyperfine by 150.0% in the third quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock worth $40,000 after purchasing an additional 30,000 shares during the period. Bank of New York Mellon Corp acquired a new position in Hyperfine in the second quarter valued at about $419,000. Renaissance Technologies LLC raised its stake in Hyperfine by 100.2% in the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after purchasing an additional 365,490 shares in the last quarter. Finally, Walleye Capital LLC lifted its position in Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after purchasing an additional 7,330 shares during the period. 15.03% of the stock is currently owned by institutional investors.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.